Perimenopause rarely begins with obvious or clearly defined symptoms.
For most women, the earliest changes are subtle, fluctuating, and often attributed to stress, ageing, or lifestyle pressures.
Clinically, however, these changes reflect instability within the hypothalamic–pituitary–ovarian (HPO) axis, resulting in irregular hormonal signalling rather than simple hormone decline.
This transition affects multiple biological systems simultaneously — endocrine regulation, neurotransmitter balance, stress response pathways, metabolic efficiency, and sleep architecture.
Understanding these early signals allows for more precise, targeted, and intelligent support.